PROPHYLIX PHARMA HOLDING AS
Signals
- Driftsunderskudd 2024 Siste driftsresultat er negativt (−71k kr).
PROPHYLIX PHARMA HOLDING AS is registered as a limited company in Tromsø, Troms with organisation number 920056245. The business is classified under manufacture of pharmaceutical preparations (NACE 21.200). The company was incorporated in 2017. Registered share capital is NOK 609,000, divided into 609130 shares. The company's stated purpose is: “Å investere i aksjer og i andre selskaper og alt som står i forbindelse med dette.”.
Key figures · 2024
Financial health · 2024
Who owns PROPHYLIX PHARMA HOLDING AS?
PROPHYLIX PHARMA HOLDING AS has 20+ registered shareholders:
- TROND MOHN FORSKNINGSSTIFTELSE 15.5%
- NORINNOVA INVEST AS 10.8%
- NORINNOVA INVEST AS 9.1%
- SARSIA SEED AS 6.4%
- NORINNOVA INVEST AS 5.8%
- SARSIA SEED AS 5.8%
- NORINNOVA INVEST AS 5.7%
- NORINNOVA AS 5.5%
- UNIVERSITETSSYKEHUSET NORD-NORGE HF 4.9%
- SARSIA SEED AS 3.6%
- SARSIA SEED AS 3.3%
- KRAKR AS 2.0%
- BJØRN RAGNAR SKOGEN 2.0%
- NORINNOVA AS 1.9%
- METTE KJÆR 1.8%
- BO JESPER HANSEN 1.8%
- METTE KJÆR 1.8%
- NORINNOVA AS 1.5%
- ANNE HUSEBEKK 1.4%
- JENS KJELDSEN-KRAGH 1.1%
Which companies does PROPHYLIX PHARMA HOLDING AS own?
PROPHYLIX PHARMA HOLDING AS holds a stake in 1 company:
- PROPHYLIX AS 100.0%
Frequently asked questions about PROPHYLIX PHARMA HOLDING AS
Who owns PROPHYLIX PHARMA HOLDING AS?
TROND MOHN FORSKNINGSSTIFTELSE is the largest registered owner, with 15.5%.
Where is PROPHYLIX PHARMA HOLDING AS based?
PROPHYLIX PHARMA HOLDING AS has its business address in Tromsø.
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.